Poster Presentations

Access to Advanced Health Institute
John Chen
Accelerated Stability and Aerosol Performance Assessment for a Spray Dried Nasal COVID-19 Vaccine Candidate
P7
Access to Advanced Health Institute
John Chen
Process Modeling for Small-Scale Manufacturing of Spray Dried Nasal Vaccine Powders
P2
Amneal Pharmaceuticals
Sunilkumar Patel
The Influence of Temperature and Humidity Control in Laboratory Settings on the Aerodynamic Particle Size Distribution of Soft Mist Inhalers
P4
Goncalo Farias and Charles Cazzola
Optimization of a Multidose Nasal Actuator Targeting Olfactory Region Deposition
P4
Pauline Faucard and Benedicte Grosjean
Leachables Assessment from a New Generation of pMDIs using Low Global Warming Potential Propellants and the Impact of Ethanol Filling
P1
Astartein
Anthony Hickey
Electronic Facemask to Enhance Patient Compliance
P3
Belhaven Biopharma
Brian Taubenheim
Pharmacokinetic Comparison of Nasal Delivered Dry Powdered Epinephrine to an Autoinjector (EpiPen®) in a Canine Model
P3
Sabrina Falloon
Using Human Factors Studies to Optimize Nozzle Geometry for Patient Interaction in the Design Development of a Unit Dose Nasal Spray
P9
Lei Mao
Development of Albuterol Sulfate Pressurized Metered Dose Inhalers using a Low Global Warming Potential Propellant 1,1-difluoroethane (HFA152a)
P15
Lei Mao
Development of Beclomethasone Dipropionate Pressurized Metered Dose Inhalers using a Low Global Warming Potential Propellant, 1,3,3,3-tetrafluoropropene (HFO1234ze)
P16
Benjamin Thorne
Investigating the Impact of Device Design and Propellant Choice on the Aerosolization of Fluticasone Propionate Suspensions in HFA152a and HFO1234ze
P10
Jufang Xu
Aerodynamic Characteristics of Spiriva® Handihaler® at Simulated Breathing Patterns of COPD and Healthy Subjects, and at a Constant Inhalation Flow using One Capsule per Determination
P16
Clair Brooks
Reducing Variability in the Inhaler Testing Environment
P2
Mirjam Kobler
Advancing DPI Technology: A Modular Approach on Optimizing Capsule Movement for Improved Performance
P9
Ameet Sule
Designing a Sustainable Ipratropium HFA-152a pMDI: Actuator Geometry Considerations
P9
Irene Rossi
Ellipta® Blister Device: A Re-Assembly Set of Tools for Early In Vitro Comparative Studies of a Complex Pre-Metered Dry Powder Inhaler
P3
Healthy Airways
Loy Britto
Development of an MDI Coated Can with a Non-PFAS Polymeric Coating
P3
Erik Boldt and Gregory Smith
Two Isn’t Always Better Than One: A Single-Actuation Salbutamol Sulfate Metered Dose Inhaler Using Low-GWP Propellant HFO-1234ze(E)
P18
Patricia Henriques and Dina Morais
Systemic Nasal Absorption of Amorphous Solid Dispersions: Supersaturating Systems for Fast Onset of Action of Poorly Soluble Drugs through the Nasal Mucosa
P16
Maria Ines Lopes and Joao Pires
Drug Load Influence on Aerodynamic Properties of High Dosage DPIs: A Case Study of an Aminoglycoside Model Drug
P24
Alexandre Ribeiro
Differential Permeability of Dry Solid and Aqueous Suspensions of Fluticasone Propionate Through A549 Alveolar Epithelial Cells
P4
Lidia Santos and Claudia Costa
Understanding Leucine Encapsulation in Dry Powder Inhaler Microparticles via Surface Characterization Techniques
P25
Måns Österberg Widerstrand and Jakob Samsøe
Novel Inhaled Anti-Viral Against SARS-CoV-2: Feasibility of Developing a Nanofitin Dry Powder Formulation for Pulmonary Delivery using the ICOone Single Dose Dry Powder Inhaler
P26
ImmuONE
Louis Scott and Ewelina Hoffman
High-Content Image Analysis for Phenotypic Characterization of Foamy Macrophage Responses of Alveolar Macrophages to Amiodarone
P2
InformiX Pharma
Parmesh Gajjar and Darragh Murnane
Novel Insight into the Microstructure of Fines-Only Formulations using X-ray Computed Tomography with Machine Learning
P1
Barry Clements
The Impact of the Universal Spacer System on Efficiency and Reliability of Dose Delivery of Inhaled Nebulized Aerosols
P2
Svetlana Lyapustina
Regulatory Topics in Nasal Product Development: Pediatrics and Reliability Expectations
P13
Jolyon Mitchell
Laser Diffraction Size Analysis of Products for Nasal Inhalation: A Survey of Expert Users
P12
Johannes Gutenberg-Universität Mainz
Moritz Fleischhauer
Tuning the Aerosol Delivery of the Respimat® Soft Mist Inhaler
P8
James Drake
Practical Considerations for Conducting Successful In Vitro Bioequivalence Studies on Inhalers
P1
Sally Stanford
An Assessment of the Effect of Vacuum Crimping on Dry Powder Filled pMDI Cans
P13
Sana Hosseini and Kimberly Shepard
Formulation of an Intranasal Dry Powder Vaccine Candidate for Tuberculosis
P1
Neerja Zambare and Kimberly Shepard
Manufacturability of Intranasal Dry Powders Spray Dried from Aqueous Solutions
P8
Ludwig-Maximilians-University Munich
Katrin Wiebe and Simone Carneiro
Impact of Vibrating Mesh Nebulization on the Physicochemical Properties of mRNA and siRNA Lipid Nanoparticle Formulations
P6
Mridul Majumder
Application of Raman Spectroscopy for Dry Powder Inhalation Formulation
P28
Macquarie University
Chun Yuen Jerry Wong
Enhancing Nose-to-Brain Drug Delivery: A Comparative Study of Peptide Formulations Using a Multidose Nasal Spray
P5
MG
Medisch Spectrum Twente
Dumiana Chamaon and Martijn F. Grinovero
Validation of the RS01X™ Smart Inhaler in a Clinical Setting
P11
Monash University
Daniel Duke
Effects of Low Global Warming Potential Propellants HFA152a and HFO1234ze(E) on the Morphology of Suspension Based Pressurized Metered Dose Inhaler Sprays
P6
Monash University
Daniel Duke and Lingzhe Rao
Manipulation of pMDI Spray Morphology via Orifice Length Variation with Propellants HFA134a, HFA227, HFA152a and HFO1234ze(E)
P7
Monash University
Rina Perven
The Fluid Dynamics of a Dry Powder Inhaler Assisted with a Zero-Net-Mass-Flux Jet
P2
Monash University
Swetha Chowdary Vutlapalli and Daniel Duke
Measurement of Vapor Pressure and Viscosity of Ethanol in HFA134a, HFA152a, and HFO1234ze(E) Mixtures used in pMDIs
P11
Will Ganley and Nuria Manzano
Comparative Assessment of Plume Velocity in pMDI Solutions: A Study using Phase Doppler Anemometry and SprayView Analysis
P8
Will Ganley
Utilizing Physiologically-based Modeling for the Design of an Inhaled Powder Formulation of Imipenem Aimed at Maximizing the Dose Delivered to the Lung Lining Fluid
P12
Nebu-Flow
Neil Fullarton
Ultrafine siRNA-laden Aerosol Using Next Generation Nebulizer
P1
Orexo AB
Jonas Sävmarker
Spray Dried Amorphous Epinephrine Nasal Powder for the Acute Treatment of Anaphylaxis
P6
Daniel Lewis
Case Studies on Reformulation of BDP MDIs using Low GWP Propellants HFO1234ze and HFA152a
P14
MS
Andrea Winzen and Martin Schlun
Aerosol Performance and Usability Evaluation of New Pediatric Facemasks for a Valved Holding Chamber
P17
Deborah Jones and Timothy Fallon
Inhalation and Exhalation Airflow Resistance of Valved Holding Chambers
P4
Lynn Jordan
Methodology for Measurement of Evaporation Fraction and Evaporation Rate: A Comparison of HFA-134a and HFA-152a pMDI Formulations
P5
Carolina Dantas
Examining User Breathing Patterns During Nebulization with a Guided Inhalation Maneuver
P3
Purdue University
Kinnari Arte
Impact of L-leucine on Stability and Aerosol Performance of Dry Powder Protein Formulations
P4
Purdue University
Shruti Sawant
Liposomal Formulation Reduces Cell Uptake of Bacteriophage in a Lung Epithelial Cell Model
P3
Resyca
Nicolas Buchmann
Assessing the Variability of In Silico Lung Deposition Predictions When Inhaling from Soft Mist Inhalers with Various Air Flow Resistances
P7
RTI International
Sara Maloney Norcross
Physicochemical and Aerodynamic Stability of Spray Dried Tigecycline Inhalation Powder for the Treatment of Pulmonary Nontuberculous Mycobacterial Infections
P5
Yannick Baschung
Unlocking the Promise of Digital Inhalers: Insights from an In Vitro Study
P10
St. John's University
Alec Diorio and Alan Watts
The Anti-Microbial Peptide, H1b, for Non-Small Cell Lung Cancer Treatment: Dry Powder Formulation Development And Characterization
P6
The University of Texas at Austin
Varsha Nair and Rex Moore
Lipid-Based Spray Dried Microparticles of Monoclonal Antibodies for Inhalation
P7
The University of Texas at Austin
Mike Sandoval and Alan Watts
Drum Filling of Thin-Film Freeze-Dried Monoclonal Antibody Powders into a Nasal Spray System
P10
The University of Texas at Austin
Jamie Spahn
A Comparison of the Aerosol Dispersion of Twelve Micronized Powders
P8
Mark Nagel
Effect of Flow Rate on Emitted Aerodynamic Particle Size Distribution from a Dry Powder Inhaler Delivering a Short-Acting Beta2 Agonist as Monotherapy
P12
U.S. Food & Drug Administration
Susan Boc
Characterization of Spray-Dried Phospholipid Porous Particles for Inhalation Drug Delivery
P10
U.S. Food & Drug Administration
Steven Chopski
Novel Method for Aerodynamic Particle Size Distribution Measurements from Respimat® Inhalers
P5
U.S. Food & Drug Administration
Nicholas Holtgrewe
Development of an In Vitro Method for In Vivo Prediction of Regional Deposition of Nasal Powders
P11
U.S. Food & Drug Administration
Nathan Reed
Characterizing Adasuve® (Loxapine, 10 mg) Inhalation Powder Particle Size Distribution Using Laser Diffraction
P11
U.S. Food & Drug Administration
Ross Walenga
Sensitivity of Charcoal Block PK Metrics to Differences in Regional Deposition for Budesonide and Formoterol Fumarate Dihydrate
P9
Universidade Estadual de Campinas
Laura Oliveira Nascimento
Effects of Surfactant Coating on Levofloxacin-Loaded Nanoparticles: Impact on Physicochemical Properties and In Vitro Cell Viability of Pulmonary Cells 
P4
Universidade Estadual de Campinas
Victoria Soares Soeiro
Enhancing Polymeric Nanodispersions for Improved Doxycycline Efficacy Against Lung Pathogen Biofilms
P5
University of Alabama at Birmingham
Blessy Joseph
The Use of Atomic Force Microscope-Infrared Spectroscopy to Assess Co-Localization of Fluticasone/Salmeterol/Lactose in Advair Diskus® 100/50 Formulations
P13
University of Bristol
Yiliang Jiang
Tandem Aerodynamic Particle Sizers Method for the Characterization of Aerosol Dynamics at Different Relative Humidities
P5
University of Hong Kong
Han Cong Seow
The Influence of Salts on Spray Dried Powder for Nasal Inhalation: Aerosol Characterization with 3D-Printed Nasal Replica
P14
University of Michigan
Nishant Shah
Evaluating Published Artificial Mucus Models for Understanding Predictability of Inhaled Drug Delivery Dynamics
P7
University of Michigan
Grace Xia
Optimization of Carbohydrate Excipient Ratios in Respirable Protein Powder Formulations
P15
University of Oklahoma
Alexa Beathard
Aerosol Performance of OHet72 Nanosuspensions Nebulized into a Custom-Made Nose-Only Dosing Chamber
P6
University of Parma
Francesca Buttini
Comparing Carbon Emissions for Three Dry Powder Inhaler Technologies
P18
University of Parma
Francesca Buttini
Effect of Ethanol Content and Actuator Orifice Diameter on the Performance of Salbutamol Sulfate pMDI Suspensions in HFO1234ze(E)
P2
University of Parma
Francesca Buttini
Tailoring of a Pramlintide Pulmonary Dry Powder for Diabetes and Obesity Treatment
P17
University of Sydney
Dipesh Khanal
Optical Photothermal Infrared Spectroscopic Assessment of Fluticasone/Salmeterol/Lactose Co-Association in Advair Diskus® and Wixela Inhub®
P14
Lara Penn
Successful Scale-Up of a Spray Dried Formulation for Nasal Drug Delivery
P15
Vast Therapeutics
Mark Schoenfisch
Efficacy of Inhaled ALX1 in a Model of Chronic Pseudomonas Aeruginosa Infection
P8
Fraser Carr
Exploration of Alternative Methodologies for Spray Pattern Evaluation in a Budesonide/Formoterol Fumarate Dihydrate pMDI
P6
Philip Smith
Bio-Based Plastics for Medical Devices: A Case Study
P27
Raneem Aldaqqa
Designing mRNA Lipid Nanoparticles for Tumor Associated Macrophages: Towards Immunotherapies for the Treatment of Osteosarcoma Lung Metastases
P9
Caleb Dalton
Pharmaceutical Aerosol Deposition in a Stainless-Steel Version of the VCU Mouth-Throat Models
P7
Caleb Dalton
Spray Characterization of Low Volume Air-Jet Dry Powder Inhaler Devices for the Delivery of a Synthetic Lung Surfactant Powder Formulation
P19
Victoria Garcia
Locally Administered Gemcitabine Chemotherapy for the Treatment of Osteosarcoma Lung Metastases
P10
Felicia Hall
Comparison of In Vitro Aerosol Performance and Powder Characteristics of a Synthetic Lung Surfactant Powder Aerosol Formulation Produced using Two Spray Drying Methods
P20
Rudra Pangeni
Efficient Delivery of Powder Aerosol to the Lungs of Small Animals with a New Air-Jet Dry Powder Insufflator
P21
Surendra Poudel
In Vivo Efficacy of Tobramycin Excipient Enhanced Growth Dry Powder Aerosol in Pseudomonas Aeruginosa Lung Infection Model
P22
Masahiro Sakagami
A Novel Hybrid Molecule of Melatonin and Curcumin: In Vivo Therapeutic Intervention in the Rat Model of Lung Fibrosis with Local Lung Delivery
P1
Morgan Thomas
Advancements in Complete-Airway Modeling of Pharmaceutical Aerosols: Implementation of a Tracheobronchial Voluming-Filling Algorithm
P8
Woolcock Institute of Medical Research
Patrick He
Comparison of In Vitro Aerosol Deposition by Salbutamol pMDI with Corrugated Tubing and Commercial Spacer
P12
Zenius
Yui Muguruma
In Vitro Aerosol Delivery Performance of the Zenius Prototype Inhaler
P23

Preparing and Displaying a Poster

Posters give you the opportunity to display innovative research and technology and interact face-to-face with conference delegates. You are also strongly encouraged to prepare an on-demand recorded presentation to share your work with all delegates. These will be posted in the appropriate online Knowledge Space through June 30 (see On-Demand Narrated Presentation Guidelines below). Taking this extra step allows all delegates to ask you questions using Messaging and means you are ready if invited to participate in Posters on the Podium.

Maximum size of your poster is 45 inches (1.1 meters) tall and 90 inches (2.2 meters) wide. Designs using text and easily interpreted, eye-catching graphics readable from 6 feet (1.8 meters) garner most attention. Focus on one or two themes and keep the design simple to emphasize your main findings. There’s no need to include a lot of background information.

Poster content must be closely related to your published abstract with all claims and conclusions supported by data or references. Do not include wildly speculative or unsubstantiated comments.

We will provide supplies to mount your posters on a board. A skirted, 15-inch (0.4 meter)-wide table beneath your poster will allow distribution of copies of your poster and other literature. It also facilitates demonstrations of small handheld devices or use of a laptop, but is unsuitable for anything heavier than 10 lbs. Posters do not have access to electricity.

Please be present at your poster to answer questions for at least an hour each time the dedicated Poster and Exhibition is scheduled. If you do not intend to stay the whole time, it is helpful to display a sign showing when you will be present. Messaging will also be available via the Conference website to encourage discussion with delegates.

If you need to ship your poster rather than hand-carry, see Shipping Instructions below.

Poster Set-up and Take-down

  • Set-up is encouraged on Sunday, May 5, between 3:00 PM to 7:00 PM. Please register at the Registration Desk in the lower level of the conference hotel and immediately proceed to the Tucson Ballroom. Our staff will direct you to your table location. Do not set up in a different location. Late arrivals may set up on Monday, May 6, from 7:30 to 9:00 AM.
  • To protect your property, hotel security will not allow access to the Poster and Exhibition area from Sunday at 7:00 PM until Monday at 7:30 AM. We recommend that you take small, high-value items such as laptops and prototype devices with you when you are not at your poster or when leaving the space for the evening.
  • A Poster and Exhibition Floor Plan will be provided to all registrants.
  • Posters must be removed at 7:00 PM on Tuesday, May 7.

Disclaimer

The meeting organizers and the JW Marriott Starr Pass expressly disclaim responsibility for loss or damage to any items you bring into the Poster and Exhibition space.

Shipping Instructions

Please ensure anyone shipping packages to the JW Marriott Starr Pass on your behalf receives a copy of these instructions. JW Marriott Starr Pass uses PostNet, located in the onsite business center, to coordinate Shipping and Receiving.


PostNet Shipping & Receiving Contact: Magda Good (magda.good@postnet.com) / 520-791-6140
Shipping and Receiving hours are 8:00 am–5:00 pm Monday through Friday.

SHIPPING SCHEDULE

Shipments should be timed to arrive between Monday, April 29, and Friday, May 3, 2024. Packages arriving outside these dates may be subject to additional PostNet storage fees as shown at the end of this document.

HANDLING FEES

Handling and storage fees will be levied and collected by PostNet for incoming and outgoing packages. If you are staying at the JW Marriott Starr Pass, charges will be added to your room. If not, PostNet will request payment by credit card according to the PostNet fee schedule.

LABELING YOUR SHIPMENT

Please attach a Main Shipping Label and Auxiliary Shipping Label to each box clearly showing the following information:

IMPORTANT INFORMATION

RDD 2024 does not accept responsibility for items delayed, lost, or damaged in transit to or from the JW Marriott Starr Pass.

  • Shipments will be brought to your exhibit table, poster location, or workshop room.
  • All international shipments are subject to customs inspection. Please ensure sufficient time for customs clearance and include “Items for trade demonstration and re-export” on the Auxiliary Shipping Label and documentation.
  • Transport and custom charges are the responsibility of the sender. Neither RDD nor the JW Marriott Starr Pass will pay transport or customs fees. Please ensure all transport and customs fees are prepaid.
  • Package fragile equipment carefully. Dangerous or suspicious looking materials should not be shipped to RDD 2024.
  • Oversize packages must be coordinated with PostNet in advance of delivery: Oversize packages (including pallets) are those that exceed any one or more of the following parameters: Height of 84” or taller, wider than 66”, greater than 300 pounds, requiring forklift, and others as determined by PostNet.

OUTGOING SHIPMENTS

  • You are responsible for organizing the packing and outgoing shipment of your materials (pack a roll of tape).
  • PostNet will collect prepaid/prelabelled outgoing packages from your exhibit table, poster, or workshop room; you will not need to schedule pick-up. FedEx, USPS, UPS and DHL (International only) provide daily weekday service to the area.
  • PostNet can arrange outgoing shipments for major carriers. Please take packages to the PostNet office (they will not be picked up from your exhibit table without a prepaid label). If you do not have an account number, you will need to make payment by credit card.

Questions?

For further information, contact Richard Dalby.

↑ Back to Top